T
here is now strong evidence that hypertension is an inflammatory disease in which T cells and T-cell-derived cytokines contribute to blood pressure elevation and endorgan damage (1, 2) . Our group was the first to demonstrate the critical role of the proinflammatory cytokine interleukin (IL)-17A in hypertension and the accompanying vascular dysfunction, using mice with genetic deletion of IL-17A (3). Subsequently, Nguyen et al. (4) showed that infusion of recombinant IL-17A into mice raised blood pressure and impaired vascular relaxation through phosphorylation of endothelial nitric oxide synthase and reduced vascular nitric oxide production. Recently, we showed that IL-17A contributes to angiotensin II (Ang II)-induced renal injury and modulates the expression of renal sodium transporters resulting in altered pressure natriuresis, whereas the related cytokine, IL-17F, had little or no effect on blood pressure, renal injury, and renal sodium chloride cotransporter activity (5,6).
The IL-17 cytokine family consists of 6 isoforms (IL-17A through IL-17F) of which IL-17A and IL-17F share the highest (50%) sequence homology (7). Both IL-17A and IL-17F are produced by similar subsets of immune cells and bind as homo-or heterodimers to the same receptor complex composed of IL-17RA and IL-17RC subunits (8) . Although IL-17A has been widely studied and found to play critical roles in the pathogenesis of many autoimmune diseases such as psoriasis and multiple sclerosis (9) , the role of IL-17F is less well characterized. IL-17F has a lower affinity for the IL-17RA receptor subunit and has been found to have overlapping, as well as distinctive functions, from IL-17A (10 Wild-type C57BL/6J mice were purchased from Jack- 
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Inhibition of IL- Data were analyzed using Student t test and expressed as mean AE SEM. *p < 0.05; **p < 0.01; ***p < 0.001 vs. WT/Sham. WT ¼ wild type.
Inhibition of IL-17 Signaling and Hypertension D E C E M B E R 2 0 1 6 : 6 0 6 -1 6 Figure 1 .
Saleh et al. FLOW CYTOMETRY. Mice were euthanized with CO 2 and transcardially perfused with phosphate buffered saline-heparin (10 U/ml) before the collection of organs. Kidney and thoracic aortic leukocytes were isolated as described previously (21) and stained using the antibodies listed in Supplemental Table 1 .
For intracellular staining, single-cell suspensions of kidneys or the whole aortae in RPMI medium supplemented with 5% fetal bovine serum were stimulated with 2 ml of BD Leukocyte Activation Cocktail (ionomycin, brefeldin A, and phorbol myristic acetate) at 37 C for 3 h. Cells were then stained using the antibodies listed in Supplemental Table 2 . was not investigated in this study, but it does raise the question of whether the beneficial effects of spironolactone, one of the most effective drugs on the market for resistant hypertension, could be due to inhibition of the IL-17A axis. Consistent with our results, these authors showed that administration of an anti-IL-17A antibody to DOCA-salt-treated rats lowered blood pressure by w20 mm Hg and reduced the expression of some profibrotic and proinflammatory mediators in the heart and kidney (19) . However, in 
